Q4 2024 Earnings Call Transcript February 11, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.63, ...

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

New packaging solution ensures all take-home products are recyclable through most curb-side programsBELVIDERE, NJ, Feb. 13, ...

Genprex’s (GNPX) research collaborators at a major cancer research center in Houston, Texas have published a new study which used the company’s ...

According to a recent study, Taiwanese researchers found that DUSP2 gene deficiency aids cancer cell growth, especially in ...

In a pioneering collaboration with AbbVie, Northwestern researchers have discovered a new way to potentially treat cancer by ...

Belvidere-based Edible Garden is bringing something new to the table. After a successful pilot production, the hydroponic ...

The research uncovers key genetic mutations that affect cancer treatment responses and develops a predictive tool for ...

A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...

There are already two drugs on the market targeting KRAS mutations, for decades considered an undruggable target, but no shortage of drug candidates hoping to follow them. At ASCO, Eli Lilly ...

Lung cancer cases are increasing in people who have never smoked, especially in women, a new study by the World Health Organization's cancer agency has found.

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...